Brought to you by 
Applied Genetic Technologies gets $15.25mm in Series A: adds $11.8mm
31 Jan 2014
Executive Summary
Applied Genetic Technologies (develops gene therapy products based on adeno-associated virus) completed its $15.25mm Series A private placement led by InterWest Partners. Also participating were InterSouth Partners, MedImmune Ventures, and Skyline Ventures.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Gene Therapy, Cell Therapy
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Applied Genetic Technologies gets $15.25mm in Series A: adds $11.8mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice